Effects of Fructan Prebiotics on the Intestinal Microbiota

NCT01277445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2015-03-10

No results posted yet for this study

Summary

Prebiotics are carbohydrate polymers believed to improve health by stimulating beneficial gastrointestinal microbial populations. Prebiotic health claims are currently not permitted in Canada due to a lack of validating scientific data. Currently, Health Canada considers 'prebiotic' to imply a health benefit that must be substantiated. Our goal is to conduct a human clinical trial to define the impacts of fructans on the colonic microbiome as well as the physiological, psychological and immunological effects on the host.

Conditions

  • Study Focus is to Define the Usual Gut Microbiota Following Prebiotic Feeding

Interventions

DIETARY_SUPPLEMENT

Prebiotic

Inulin-fructan 15mg/day for 28days

DIETARY_SUPPLEMENT

Prebiotic

Daily consumption of 15g inulin-fructan for 28 days

Sponsors & Collaborators

  • Health Canada

    collaborator OTHER_GOV
  • Advance Foods and Materials Network

    collaborator OTHER
  • University of Ontario Institute of Technology

    collaborator OTHER
  • University of Lethbridge

    collaborator OTHER
  • Dan Ramdath

    lead OTHER_GOV

Principal Investigators

  • Dan Ramdath, PhD · Guelph Food Research Centre

  • Martin Kalmokoff, PhD · Agriculture and Agri-Food Canada

  • Steven Traplin, MD · Nutrasource Diagnostic Inc

  • Maggie Laidlaw, PhD · Nutrasource Diagnostic Inc

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-03-31
Completion
2013-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01277445 on ClinicalTrials.gov